ANALYSIS OF ADVERSE DRUG REACTIONS (ADRs) AND THEIR SEVERITY IN BREAST CANCER PATIENTS TREATED WITH THE DOCETAXEL-DOXORUBICIN REGIMEN AT SULTAN AGUNG ISLAMIC HOSPITAL
Quantitative analysis reveals incidence of adverse drug reactions in breast cancer patients, indicating critical safety concerns.
Key Points
Breast cancer patients treated with the docetaxel-doxorubicin regimen experienced various adverse drug reactions, with nausea as the most frequent.
Out of 591 recorded adverse drug reactions incidents, 55.6% were identified as mild, while anemia and alopecia were notable in moderate and severe categories respectively.
The study employed a quantitative cross-sectional approach, utilizing purposive sampling to gather data on adverse drug reactions.
These findings may highlight the need for monitoring and managing adverse drug reactions in patients undergoing chemotherapy.